Chinese General Practice ›› 2022, Vol. 25 ›› Issue (20): 2457-2461.DOI: 10.12114/j.issn.1007-9572.2022.0089
Special Issue: 内分泌代谢性疾病最新文章合辑; 肥胖最新文章合辑
• Article • Previous Articles Next Articles
Received:
2021-12-23
Revised:
2022-03-01
Published:
2022-07-15
Online:
2022-03-24
Contact:
Lianxi LI
About author:
通讯作者:
李连喜
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0089
项目 | T2DM无肥胖组(n=1 609) | T2DM肥胖组(n=1 414) | 检验统计量值 | P值 |
---|---|---|---|---|
年龄(岁) | 59±13 | 58±13 | 2.110a | 0.441 |
性别(男/女) | 904/705 | 816/598 | 0.713b | 0.398 |
糖尿病病程〔M(P25,P75),月〕 | 84(16,144) | 72(24,132) | -0.600 | 0.879 |
吸烟史〔n(%)〕 | 466(29.0) | 426(30.1) | 0.491b | 0.483 |
饮酒史〔n(%)〕 | 231(14.4) | 255(18.0) | 7.542b | 0.006 |
高血压病史〔n(%)〕 | 735(45.7) | 857(60.6) | 67.274b | <0.001 |
降压药用药史〔n(%)〕 | 650(40.4) | 805(56.9) | 82.401b | <0.001 |
收缩压(mm Hg) | 130±17 | 134±17 | 6.455a | <0.001 |
舒张压(mm Hg) | 79±9 | 82±10 | 8.681a | <0.001 |
腰臀比 | 0.89±0.06 | 0.94±0.06 | 22.861a | <0.001 |
FPG〔M(P25,P75),mmol/L〕 | 7.53(6.00,9.65) | 7.91(6.51,9.89) | -4.152 | <0.001 |
2 hPG〔M(P25,P75),mmol/L〕 | 13.14(9.43,16.49) | 13.93(10.88,17.05) | -5.686 | <0.001 |
Scr〔M(P25,P75),μmol/L〕 | 65(54,78) | 68(57,82) | -4.073 | 0.007 |
HbA1c(%) | 9.25±2.52 | 9.02±2.23 | 2.641a | 0.018 |
空腹C肽〔M(P25,P75),μmol/L〕 | 1.37(0.76,2.02) | 1.98(1.33,2.83) | -16.444 | <0.001 |
餐后2 hC肽〔M(P25,P75),μmol/L〕 | 2.96(1.48,4.80) | 4.29(2.72,5.65) | -14.447 | <0.001 |
TG〔M(P25,P75),mmol/L〕 | 1.22(0.86,1.78) | 1.73(1.21,2.49) | -16.610 | <0.001 |
TC(mmol/L) | 4.63±1.15 | 4.78±1.12 | 3.622a | <0.001 |
HDL(mmol/L) | 1.18±0.33 | 1.04±0.27 | 12.658a | <0.001 |
LDL(mmol/L) | 3.04±0.98 | 3.13±0.90 | 2.617a | 0.007 |
ALT〔M(P25,P75),U/L〕 | 17(12,25) | 23(15,37) | -11.595 | <0.001 |
血尿酸〔M(P25,P75),μmol/L〕 | 291(241,348) | 337(276,397) | -12.760 | <0.001 |
Table 1 Comparison of general clinical features between T2DM patients without and with obesity
项目 | T2DM无肥胖组(n=1 609) | T2DM肥胖组(n=1 414) | 检验统计量值 | P值 |
---|---|---|---|---|
年龄(岁) | 59±13 | 58±13 | 2.110a | 0.441 |
性别(男/女) | 904/705 | 816/598 | 0.713b | 0.398 |
糖尿病病程〔M(P25,P75),月〕 | 84(16,144) | 72(24,132) | -0.600 | 0.879 |
吸烟史〔n(%)〕 | 466(29.0) | 426(30.1) | 0.491b | 0.483 |
饮酒史〔n(%)〕 | 231(14.4) | 255(18.0) | 7.542b | 0.006 |
高血压病史〔n(%)〕 | 735(45.7) | 857(60.6) | 67.274b | <0.001 |
降压药用药史〔n(%)〕 | 650(40.4) | 805(56.9) | 82.401b | <0.001 |
收缩压(mm Hg) | 130±17 | 134±17 | 6.455a | <0.001 |
舒张压(mm Hg) | 79±9 | 82±10 | 8.681a | <0.001 |
腰臀比 | 0.89±0.06 | 0.94±0.06 | 22.861a | <0.001 |
FPG〔M(P25,P75),mmol/L〕 | 7.53(6.00,9.65) | 7.91(6.51,9.89) | -4.152 | <0.001 |
2 hPG〔M(P25,P75),mmol/L〕 | 13.14(9.43,16.49) | 13.93(10.88,17.05) | -5.686 | <0.001 |
Scr〔M(P25,P75),μmol/L〕 | 65(54,78) | 68(57,82) | -4.073 | 0.007 |
HbA1c(%) | 9.25±2.52 | 9.02±2.23 | 2.641a | 0.018 |
空腹C肽〔M(P25,P75),μmol/L〕 | 1.37(0.76,2.02) | 1.98(1.33,2.83) | -16.444 | <0.001 |
餐后2 hC肽〔M(P25,P75),μmol/L〕 | 2.96(1.48,4.80) | 4.29(2.72,5.65) | -14.447 | <0.001 |
TG〔M(P25,P75),mmol/L〕 | 1.22(0.86,1.78) | 1.73(1.21,2.49) | -16.610 | <0.001 |
TC(mmol/L) | 4.63±1.15 | 4.78±1.12 | 3.622a | <0.001 |
HDL(mmol/L) | 1.18±0.33 | 1.04±0.27 | 12.658a | <0.001 |
LDL(mmol/L) | 3.04±0.98 | 3.13±0.90 | 2.617a | 0.007 |
ALT〔M(P25,P75),U/L〕 | 17(12,25) | 23(15,37) | -11.595 | <0.001 |
血尿酸〔M(P25,P75),μmol/L〕 | 291(241,348) | 337(276,397) | -12.760 | <0.001 |
项目 | 赋值 | 项目 | 赋值 |
---|---|---|---|
年龄 | 实测值 | 2 hPG | 实测值 |
性别 | 男=0,女=1 | Scr | 实测值 |
糖尿病病程 | 实测值 | HbA1c | 实测值 |
吸烟史 | 不吸烟=0,吸烟=1 | 空腹C肽 | 实测值 |
饮酒史 | 不饮酒=0,饮酒=1 | 餐后2 hC肽 | 实测值 |
高血压病史 | 无=0,有=1 | TG | 实测值 |
降压药用药史 | 无=0,有=1 | TC | 实测值 |
收缩压 | 实测值 | HDL | 实测值 |
舒张压 | 实测值 | LDL | 实测值 |
腰臀比 | 实测值 | ALT | 实测值 |
FPG | 实测值 | 血尿酸 | 实测值 |
Table 2 Assignment for variables possibly,independently associated with the correlation between obesity and albuminuria in T2DM patients assessed using binary Logistic regression analysis
项目 | 赋值 | 项目 | 赋值 |
---|---|---|---|
年龄 | 实测值 | 2 hPG | 实测值 |
性别 | 男=0,女=1 | Scr | 实测值 |
糖尿病病程 | 实测值 | HbA1c | 实测值 |
吸烟史 | 不吸烟=0,吸烟=1 | 空腹C肽 | 实测值 |
饮酒史 | 不饮酒=0,饮酒=1 | 餐后2 hC肽 | 实测值 |
高血压病史 | 无=0,有=1 | TG | 实测值 |
降压药用药史 | 无=0,有=1 | TC | 实测值 |
收缩压 | 实测值 | HDL | 实测值 |
舒张压 | 实测值 | LDL | 实测值 |
腰臀比 | 实测值 | ALT | 实测值 |
FPG | 实测值 | 血尿酸 | 实测值 |
模型 | B | SE | OR(95%CI) | Wald χ2值 | P值 |
---|---|---|---|---|---|
模型1 | 0.550 | 0.086 | 1.733(1.463,2.052) | 40.578 | <0.001 |
模型2 | 0.377 | 0.090 | 1.458(1.222,1.740) | 17.555 | <0.001 |
模型3 | 0.277 | 0.097 | 1.319(1.092,1.594) | 8.238 | 0.004 |
模型4 | 0.236 | 0.114 | 1.266(1.013,1.582) | 4.299 | 0.038 |
Table 3 Binary Logistic regression analysis of the correlation between obesity and albuminuria in T2DM patients
模型 | B | SE | OR(95%CI) | Wald χ2值 | P值 |
---|---|---|---|---|---|
模型1 | 0.550 | 0.086 | 1.733(1.463,2.052) | 40.578 | <0.001 |
模型2 | 0.377 | 0.090 | 1.458(1.222,1.740) | 17.555 | <0.001 |
模型3 | 0.277 | 0.097 | 1.319(1.092,1.594) | 8.238 | 0.004 |
模型4 | 0.236 | 0.114 | 1.266(1.013,1.582) | 4.299 | 0.038 |
[1] |
|
[2] |
|
[3] |
沈雯雯,刘志红,陈慧梅,等. 肥胖相关性肾病:体重指数与蛋白尿的关系[J]. 肾脏病与透析肾移植杂志,2009,18(6):504-512,547. DOI:10.3969/j.issn.1006-298X.2009.06.002.
|
[4] |
|
[5] |
卢锐锋,范婉华. 2型糖尿病患者肥胖不同指标与尿微量白蛋白的相关性研究[J]. 中国实用医药,2019,14(34):104-105. DOI:10.14163/j.cnki.11-5547/r.2019.34.054.
|
[6] |
周雁,郭立新,于冬妮,等. 1758例2型糖尿病住院患者糖尿病肾病的相关因素分析[J]. 中华流行病学杂志,2012,33(6):610-613. DOI:10.3760/cma.j.issn.0254-6450.2012.06.015.
|
[7] |
卫生部疾病控制司,中华医学会糖尿病学分会. 《中国糖尿病防治指南》(试行本)(节选)[J]. 中国慢性病预防与控制,2004,12(6):283-285. DOI:10.3969/j.issn.1004-6194.2004.06.022.
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
雷娟,周淑娴,薛声能,等. 微量白蛋白尿与代谢紊乱关系的探讨[J]. 中国临床实用医学,2008,2(3):16-17.
|
[14] |
|
[15] |
|
[16] |
|
[17] |
|
[1] | ZHANG Peng, LIU Lidi, ZHANG Ying, YANG Ziyu, LIU Changming, TANG Yijun, LIAO Xiaoyang, JIA Yu. Interpretation and Clinical Implications of the 2024 Italian Guidelines for the Management of Adult Individuals with Overweight and Obesity and Metabolic Comorbidities That are Resistant to Behavioral Treatment [J]. Chinese General Practice, 2025, 28(30): 3747-3752. |
[2] | LU Donglei, YANG Fengying, FENG Zhanpeng, CAO Liquan, TAN Sijie. Conccurent Training Can Improve the Physical Health in Diabesity Individuals: a Meta-analysis [J]. Chinese General Practice, 2025, 28(27): 3410-3421. |
[3] | QUAN Jialin, ZHU Lin, SU Yu, CHEN Zekai, CHEN Ziqi, ZHANG Zhuofan. Research on the Improvement Effect of Exercise Modes on the Executive Function of Overweight or Obese Children or Adolescents: a Network Meta-analysis [J]. Chinese General Practice, 2025, 28(27): 3422-3431. |
[4] | ZHANG Yunuo, LI Ruibin, WANG Wei. Correlation Analysis of Serum Nesfatin-1 and Ghrelin Levels with Glycolipid Metabolism and Type 2 Diabetes Mellitus [J]. Chinese General Practice, 2025, 28(26): 3264-3270. |
[5] | HU Jieman, TAN Feixiang, YUAN Anxin, CHEN Shiyu, TANG Chulei, YIN Yueheng, BA Lei, XU Qin. Analysis of the Trajectory of Postoperative Frailty and Influencing Factors in Patients with Colorectal Cancer [J]. Chinese General Practice, 2025, 28(26): 3276-3282. |
[6] | CHOU Xintong, PENG Hanyu, MA Hui, ZHANG Zhen, SU Xian, QIU Hongyan. Maternal Preferences in Contraceptive Decision-making: an Analysis of Influencing Factors [J]. Chinese General Practice, 2025, 28(26): 3294-3299. |
[7] | WEI Jiaohua, PENG Huiru, PENG Jianye, TAN Wenting, HUANG Jine, FANG Li. Expression of the Serum MOTS-c and Its Correlation with Atrial Remodeling in Patients with Atrial Fibrillation [J]. Chinese General Practice, 2025, 28(26): 3271-3276. |
[8] | XIANG Xinyue, ZHANG Bingqing, OUYANG Yuqin, TANG Wenjuan, FENG Wenhuan. Impact of Short-term Medical Weight Loss on Atherosclerotic Cardiovascular Disease Risk in Patients with Obesity [J]. Chinese General Practice, 2025, 28(26): 3229-3239. |
[9] | YU Zizi, LIU Duli, LI Ximin, RUAN Chunyi, YIN Xiangyang, CAI Le. Analysis of the Prevalence and Self-management of Hypertension and Its Influencing Factors in Rural [J]. Chinese General Practice, 2025, 28(25): 3137-3143. |
[10] | FAN Boyang, ZHANG Yu, SUN Wenning, ZHANG Huifang, WANG Yingjie, ZHANG Ao, ZHAO Yang, WANG Haipeng. Study of Behavioral Intention and Influencing Factors of Integrated Medical and Preventive Care Provided by Grassroots Doctors for Patients with Chronic Diseases [J]. Chinese General Practice, 2025, 28(25): 3144-3150. |
[11] | WANG Rupeng, NAN Jing, HU Yiran, YANG Shenghua, JIN Zening. Predictive Value of the Triglyceride-Glucose Body Mass Index for Slow Flow/No-reflow Phenomenon in Patients with Type 2 Diabetes Mellitus and Acute Myocardial Infarction Undergoing Emergency Percutaneous Coronary Intervention [J]. Chinese General Practice, 2025, 28(24): 2985-2992. |
[12] | WEI Yunhong, YANG Li, WANG Yulu, YE Qiufang, DAI Anni, HE Yan. Study on Cardiopulmonary Function During Different Exercise Stages in Patients with Obesity-related Hypertension [J]. Chinese General Practice, 2025, 28(24): 2972-2978. |
[13] | WU Yue, WANG Xuetong, KE Bilian. Evaluation of Vision-related Quality of Life in Myopic Macular Degeneration Patients with Low Vision and Associated Factors [J]. Chinese General Practice, 2025, 28(23): 2908-2914. |
[14] | DING Zijun, ZHOU Nannan, LUO Xing, LUO Jieyu, HAO Wenjuan, ZHANG Chunjiang, JIN Xin, ZHAO Dan. Cognitive Impairment in Patients on Maintenance Hemodialysis and Its Influencing Factors: a Multicenter Cross-sectional Study [J]. Chinese General Practice, 2025, 28(23): 2885-2893. |
[15] | WEI Xiaoxia, CHEN Nuo, WANG Juanjuan, ZHU Jingfen. The Effects of Depression and Anxiety on Smoking Behavior among Vocational School Students [J]. Chinese General Practice, 2025, 28(22): 2826-2832. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||